Propranolol Dosing for Migraine Prophylaxis
For migraine prophylaxis in adults, start propranolol at 80 mg daily and titrate to a target maintenance dose of 160-240 mg daily, divided into 2-3 doses or given once daily as extended-release formulation. 1, 2
Starting and Titration Strategy
Begin with 80 mg once daily (extended-release) or 40 mg twice daily (immediate-release). Increase the dose gradually at 3-7 day intervals until optimal response is achieved or side effects limit further increases 2. The goal is to reach the therapeutic range while monitoring for tolerability.
Target Maintenance Dose
The evidence-supported effective dose range is 160-240 mg daily 1, 3. This represents the sweet spot where most patients achieve meaningful migraine reduction:
- Multiple high-quality guidelines consistently recommend 80-240 mg/day as first-line therapy 1, 3
- The FDA-approved dosing for extended-release formulations specifies 160-240 mg once daily as the usual effective range 2
- Research demonstrates that 160 mg daily provides significantly better migraine control than 80 mg daily 4
Dosing Nuances
Lower doses (80-160 mg/day) work for many patients: Research shows approximately 73% of patients respond to doses around 1 mg/kg/day (roughly 80-100 mg for average adults), with only about one-third requiring higher doses 5. Start conservatively and increase only if needed.
Maximum dose is 320-640 mg/day: While most patients respond to 160-240 mg daily, some require up to 320 mg/day 6, 7. The FDA label mentions doses up to 640 mg/day for hypertension, though this is rarely needed for migraine 2.
Formulation Considerations
- Extended-release: 80-240 mg once daily (preferred for convenience and compliance) 2
- Immediate-release: Divide total daily dose into 2-3 administrations 1
- Extended-release is NOT a simple mg-for-mg substitute for immediate-release; retitration may be necessary 2
Timeline for Response
Allow 4-6 weeks at the target dose before declaring treatment failure 2. Clinical benefits may take 2-3 months to fully manifest 3. The success rate progressively increases throughout the first year of treatment 7.
Common Pitfalls
Underdosing is prevalent: Clinical experience suggests many patients receive suboptimal doses (often 80-120 mg/day) when they would benefit from 160-240 mg/day 6. Don't stop at 80 mg if the patient tolerates it but still has frequent migraines.
Abrupt discontinuation: When stopping propranolol, taper gradually over several weeks to avoid rebound phenomena 2.
Comparative Context
Propranolol (80-240 mg/day) is recommended as a first-line preventive agent alongside timolol, amitriptyline, and divalproex sodium 1, 3. A 2020 pediatric guideline and 2025 ACP guideline both support propranolol as an evidence-based option, though newer CGRP antagonists are now available 8, 9, 10.
Side effects to monitor: Fatigue, depression, nausea, dizziness, and insomnia are common but generally well-tolerated 1. These rarely cause treatment discontinuation at therapeutic doses.